Topics
Glioblastoma | Outcomes | Neoadjuvant Chemotherapy
Home > Publications > Topics > Glioblastoma > Outcomes > Neoadjuvant Chemotherapy
*Sharifian A, Kazemian A, Farzin M, Amirkhani N, Farazmand B,
Naderi S, Khalilian A, Pourrashidi A, Amjad G, Kolahdouzan K,
Abyaneh R, Jablonska PA, Ghalehtaki R.
Postoperative
NEOadjuvant TEMozolomide followed by
chemoradiotherapy versus upfront
chemoradiotherapy for glioblastoma multiforme
(NEOTEM) trial: Interim results.
Neurooncol
Adv. 2024 Nov 14;6(1):vdae195. doi:
10.1093/noajnl/vdae195. PMID:
39664679. Interventional study. ˍ